Market revenue in 2022 | USD 20.7 million |
Market revenue in 2030 | USD 32.3 million |
Growth rate | 5.7% (CAGR from 2022 to 2030) |
Largest segment | Bone access devices |
Fastest growing segment | Balloon Catheters |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Balloon Catheters, Bone Access Devices, Cement Application Products, Instruments |
Key market players worldwide | Stryker Corp, Medtronic PLC, Smith & Nephew PLC, MicroPort Scientific Corp, Johnson & Johnson, Halma PLC, CareFusion, Merit Medical Systems Inc, iMedicom, Seawon Meditech, Joline, G21, Joimax |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to kyphoplasty market will help companies and investors design strategic landscapes.
Bone access devices was the largest segment with a revenue share of 42.03% in 2022. Horizon Databook has segmented the France kyphoplasty market based on balloon catheters, bone access devices, cement application products, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
France’s national healthcare system established an exclusive positive coverage for the triangular iFuse Implant System for spine and MIS SI joint fusion. In August 2018, SI-Bone announced that iFuse has been added to the List of Refundable Products and Services in France and stated that the French National Healthcare System exclusively covers the iFuse procedure.
The products are used in minimally invasive surgical treatment of spine through the iFuse Implant System. Reimbursement, which is exclusive to the iFuse implant, established following the favorable opinion of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS), began in September 2018 and was effective for an initial period of 5 years.
The CNEDIMTS concluded that the iFuse procedure exhibited outcomes, including improvements in quality of life and work status, which are sufficient to include iFuse on the list of products and services, in December 2017.
Horizon Databook provides a detailed overview of country-level data and insights on the France kyphoplasty market , including forecasts for subscribers. This country databook contains high-level insights into France kyphoplasty market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account